Lung Cancer-Other Treatment
Links shared publicly online about this topic.
- 1,011total visits
Lung Cancer-Other Treatment
View full resource at webmd.com
Tags: Cancer, Lung Cancer, Lung, Imaging Tests, X-Ray
Most Recently Shared on July 19, 2010 at 3:31 pm By:
6 Types of Therapies for Lung Cancer http://bit.ly/dCfDvu
Mayo Clinic experts available to discuss mental health challenges faced by cancer survivors
news-medical.net — “April is National Cancer Control Month, which focuses on the prevention, detection, and treatment of cancer and on efforts to improve the quality of life of the more than 11 million cancer survivors in the United States.” View full resource at news-medical.net
Most Recently Shared on April 12, 2012 at 11:57 am By:
Lung Cancer News: Mayo Clinic experts available to discuss mental health challenges faced by cancer survivors: A... http://t.co/s9xYpxLl
Majority of Michigan oncology practices follow treatment guidelines for common cancers
news-medical.net — “A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.” View full resource at news-medical.net
Most Recently Shared on April 11, 2012 at 7:10 am By:
Breast Cancer News: Majority of Michigan oncology practices follow treatment guidelines for common cancers: A ma... http://t.co/ANozn5SF
Opportunity for developers and marketers of EGFR inhibitors in Brazil and Mexico
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that patient access to premium-priced targeted cancer treatments in Brazil and Mexico is improving, creating an opportunity for developers and marketers of epidermal growth factor receptor (EGFR) inhibitors.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 2:18 pm By:
Breast Cancer News: Opportunity for developers and marketers of EGFR inhibitors in Brazil and Mexico: Decision R... http://t.co/GzA99dJb
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
Combination treatment shows promise against NSCLC patients ineligible for bevacizumab
news-medical.net — “A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 4, 2012 at 11:27 am By:
Lung Cancer News: Combination treatment shows promise against NSCLC patients ineligible for bevacizumab: A combi... http://t.co/vU5W9EYs
Glaxo Lifts Theravance Stake - WSJ.com
online.wsj.com — “GlaxoSmithKline underscored how important the experimental drug Relovair is for its future by lifting its stake in the lung treatment's U.S.-based developer Theravance.” View full resource at online.wsj.com
Most Recently Shared on April 2, 2012 at 3:56 pm By:
Glaxo Lifts Theravance Stake http://t.co/4Nnxuf5S
Cancer docs often don't notice family discord | Reuters
reuters.com — “NEW YORK (Reuters Health) - Doctors caring for lung cancer patients are often unaware when patients and their caregivers disagree about the best course of treatment, according to a new study.Unless you're” View full resource at reuters.com
Most Recently Shared on March 28, 2012 at 8:51 pm By:
Cancer docs often don't notice family discord http://t.co/vQ7GMlVD
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibitor CO-1686 - Yahoo! News
news.yahoo.com — “From Yahoo! News: Clovis Oncology, Inc. (Nasdaq: CLVS) announced today that the first clinical study of CO-1686 has commenced with the dosing of the first patient at a U.S. study site. CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations currently being studied for the treatment of non-small cell lung cancer (NSCLC).” View full resource at news.yahoo.com
Most Recently Shared on March 28, 2012 at 11:04 am By:
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibit... http://t.co/48JzhFAO
Clinical trial to test success of Cystic Fibrosis lung infection treatment
medicalxpress.com — “Experts from Bristol and Nottingham are leading a major new national study to investigate whether intravenous antibiotics are effective in killing a common germ that causes dangerous complications in cystic fibrosis (CF) patients.” View full resource at medicalxpress.com
Most Recently Shared on March 27, 2012 at 2:46 pm By:
PhysOrg Health News Health News
Clinical trial to test success of Cystic Fibrosis lung infection treatment http://t.co/imTyDyrA
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 9:16 pm By:
ASH Hematology and Health Organization
J&J drug shines in trial against standard lung-clot drugs http://t.co/nP63qmta via @reuters
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
medicalxpress.com — “A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism – a blockage of lung blood vessels usually caused by a clot – and showed comparable efficacy, according to data from the EINSTEIN-PE ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 3:30 pm By:
PhysOrg Health News Health News
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels http://t.co/tyxObO6R
J&J drug shines in trial against standard lung-clot drugs
health.yahoo.net — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in h.” View full resource at health.yahoo.net
Most Recently Shared on March 26, 2012 at 2:50 pm By:
Jane Anderson Healthy Eating Advisor
J&J drug shines in trial against standard lung-clot drugs http://t.co/288cvE0l
J&J drug shines in trial against standard lung-clot drugs - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in hospitals. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 2:48 pm By:
HealthTrendster Health Executive
J&J drug shines in trial against standard lung-clot drugs - CHICAGO (Reuters) - Johnson & Johnson's blood clot preve... http://t.co/wf9CH1yx
J&J drug shines in trial against standard lung-clot drugs - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in hospitals. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 1:33 pm By:
J&J drug shines in trial against standard lung-clot drugs: CHICAGO (Reuters) - Johnson & Johnson's blood clot pr... http://t.co/SnaALqXK
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 1:31 pm By:
J&J drug shines in trial against standard lung-clot drugs: CHICAGO (Reuters) - Johnson & Johnson's... http://t.co/DczfFnLw #health #news
Advertisement
